Catalyst Pharmaceuticals Inc. Revenue 2012–2025
Catalyst Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2012 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Catalyst Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 149.4 M, a 5.63% increase year-over-year.
- Catalyst Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 585.8 M, a 29.42% increase year-over-year.
- Catalyst Pharmaceuticals Inc. annual revenue for 2025 was 589.0 M, a 19.78% increase from 2024.
- Catalyst Pharmaceuticals Inc. annual revenue for 2024 was 491.7 M, a 23.49% increase from 2023.
- Catalyst Pharmaceuticals Inc. annual revenue for 2023 was 398.2 M, a 85.90% increase from 2022.
- Catalyst Pharmaceuticals Inc. annual revenue for 2022 was 214.2 M.
Catalyst Pharmaceuticals Inc. (CPRX) — Frequently Asked Questions
Catalyst Pharmaceuticals Inc. (CPRX) is a publicly traded US company. It has a market capitalization of $3.99B. In fiscal 2025 it reported revenue of $589M and net income of $214M. Explore CPRX's stock price, financial statements, earnings history, margins and key ratios below.
What is Catalyst Pharmaceuticals Inc.'s market cap?
Catalyst Pharmaceuticals Inc. (CPRX) has a market capitalization of $3.99B.
What is the CPRX stock price?
CPRX trades at $31.34.
How much revenue does Catalyst Pharmaceuticals Inc. make?
Catalyst Pharmaceuticals Inc. reported revenue of $589M in fiscal 2025.
Is CPRX profitable?
In fiscal 2025, Catalyst Pharmaceuticals Inc. reported net income of $214M.